CES2
Basic information
Region (hg38): 16:66934444-66945096
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CES2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 33 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 10 | |||||
Total | 0 | 0 | 42 | 5 | 1 |
Variants in CES2
This is a list of pathogenic ClinVar variants found in the CES2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-66935448-C-G | Likely benign (Jun 15, 2018) | |||
16-66935493-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
16-66935528-A-T | not specified | Uncertain significance (Aug 19, 2024) | ||
16-66935529-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
16-66935536-G-T | not specified | Uncertain significance (Oct 06, 2024) | ||
16-66935541-G-A | not specified | Uncertain significance (Jul 11, 2023) | ||
16-66935571-C-T | not specified | Uncertain significance (Aug 31, 2022) | ||
16-66935580-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
16-66935607-G-A | not specified | Uncertain significance (Dec 03, 2024) | ||
16-66935620-G-T | not specified | Uncertain significance (Sep 25, 2023) | ||
16-66935654-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
16-66935658-C-A | not specified | Uncertain significance (Dec 07, 2024) | ||
16-66935686-T-C | Likely benign (Dec 01, 2022) | |||
16-66935703-G-A | not specified | Likely benign (Apr 12, 2024) | ||
16-66938099-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
16-66938190-A-C | not specified | Uncertain significance (Oct 03, 2022) | ||
16-66938235-C-G | not specified | Uncertain significance (Dec 03, 2024) | ||
16-66939219-G-A | not specified | Uncertain significance (Apr 19, 2024) | ||
16-66939330-C-T | not specified | Uncertain significance (Oct 27, 2021) | ||
16-66939356-C-G | not specified | Uncertain significance (Oct 12, 2022) | ||
16-66940239-C-T | Likely benign (Dec 01, 2022) | |||
16-66940249-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
16-66940478-A-G | not specified | Uncertain significance (Feb 17, 2023) | ||
16-66940516-G-C | not specified | Uncertain significance (Jul 21, 2021) | ||
16-66940541-G-A | not specified | Uncertain significance (Aug 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CES2 | protein_coding | protein_coding | ENST00000317091 | 12 | 10653 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.58e-16 | 0.0203 | 125568 | 0 | 180 | 125748 | 0.000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.372 | 351 | 371 | 0.946 | 0.0000220 | 4068 |
Missense in Polyphen | 93 | 120.47 | 0.772 | 1445 | ||
Synonymous | 0.514 | 150 | 158 | 0.948 | 0.0000104 | 1272 |
Loss of Function | 0.374 | 25 | 27.1 | 0.922 | 0.00000129 | 279 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00268 | 0.00268 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000489 | 0.000489 |
Finnish | 0.000555 | 0.000554 |
European (Non-Finnish) | 0.000538 | 0.000536 |
Middle Eastern | 0.000489 | 0.000489 |
South Asian | 0.000556 | 0.000555 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs (PubMed:9169443). Shows high catalytic efficiency for hydrolysis of cocaine, 4- methylumbelliferyl acetate, heroin and 6-monoacetylmorphine (PubMed:9169443). Hydrolyzes aspirin, substrates with large alcohol group and small acyl group and endogenous lipids such as triacylglycerol (PubMed:28677105). {ECO:0000269|PubMed:9169443, ECO:0000303|PubMed:28677105}.;
- Pathway
- Drug metabolism - other enzymes - Homo sapiens (human);Fluoropyrimidine Pathway, Pharmacokinetics;Mycophenolic acid Pathway, Pharmacokinetics;Mycophenolic acid Pathway, Pharmacokinetics/Pharmacodynamics;Irinotecan Pathway, Pharmacokinetics;Irinotecan Pathway, Pharmacodynamics;Mycophenolic Acid Metabolism Pathway;Heroin Metabolism Pathway;Irinotecan Action Pathway;Heroin Action Pathway;Irinotecan Metabolism Pathway;Phase I biotransformations, non P450;Fluoropyrimidine Activity;Irinotecan Pathway;Heroin metabolism;Nuclear Receptors Meta-Pathway;NRF2 pathway;Phase I - Functionalization of compounds;Biological oxidations;Metabolism;retinol biosynthesis;E2F transcription factor network
(Consensus)
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- loftool
- 0.930
- rvis_EVS
- -0.86
- rvis_percentile_EVS
- 10.85
Haploinsufficiency Scores
- pHI
- 0.0726
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.475
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.297
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ces2h
- Phenotype
Gene ontology
- Biological process
- prostaglandin metabolic process;xenobiotic metabolic process;catabolic process
- Cellular component
- extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen
- Molecular function
- methylumbelliferyl-acetate deacetylase activity;carboxylic ester hydrolase activity